Jaguar Health (JAGX) Land & Improvements (2017 - 2018)
Jaguar Health (JAGX) reported Land & Improvements of $396247.0 for Q1 2018, little changed quarter-over-quarter from $396247.0 in Q4 2017.
Jaguar Health (JAGX) Land & Improvements (2017 - 2018) Analysis & Trends
Jaguar Health (JAGX) has 2 years of Land & Improvements data on file, last reported at $396247.0 in Q1 2018.
- Land & Improvements for Q1 2018 came in at $396247.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2018 was $396247.0 (changed N/A YoY), and the FY2017 annual result was $396247.0, changed N/A from the prior year.
- Land & Improvements was little changed at $396247.0 in Q1 2018 per JAGX's latest filing, from $396247.0 in the prior quarter.
- Over five years, Land & Improvements peaked at $396247.0 in Q4 2017 and troughed at $396247.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 396,247.00 |
| Dec 31, 2017 | 396,247.00 |